Disappointing results with idasanutlin in children with solid tumors (2024) In children and young adults with neuroblastoma or other solid tumors, the drug idasanutlin did not work as well as hoped.
Improving treatment of relapsed neuroblastoma (Moreno et al., 2024) Adding the drug bevacizumab to chemotherapy results in more children with relapsed neuroblastoma responding to treatment.
New immunotherapy target in neuroblastoma (Wienke et al., 2024) A detailed 'atlas' of neuroblastoma tumors points to a new target for immunotherapy.
Better and faster visibility of neuroblastoma with mFBG PET-CT scans (Samim et al., 2023) Neuroblastoma tumors are becoming more accurately and quickly visible on scans thanks to a small modification in the radioactive agent used for this purpose.
Concentration of surgery has improved operations for neuroblastoma (Van der Steeg et al., 2023) Operating on children with neuroblastoma in one location in the Netherlands has led to better treatment results.
Checkpoint inhibitors in the treatment of pediatric solid tumors (Geoerger et al., 2020) In this study researchers determined whether the drug atezolizumab, a so-called checkpoint inhibitor, was active and safe to use in children with solid tumors, including neuroblastoma.